Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

MDT

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

MDT

AI Research Report

Powered by Claude

Ready to analyze MDT

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

C+
Stonvex Quant Grade
50.0/ 100
Rank-normalised composite of 6 factors, updated every 60 seconds.
Volume
C+
50 / 100

Today's volume vs prior session average.

Volatility
C+
50 / 100

Absolute daily price move vs peers.

News Flow
C+
50 / 100

24h article count relative to the universe.

Sentiment
C+
50 / 100

AI-classified polarity of recent news.

Dollar Flow
C+
50 / 100

Today's dollar turnover (volume × VWAP).

Relative Strength
C+
50 / 100

Signed daily return vs the rest of the universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Similar stocks

View all Healthcare →
LLY
Eli Lilly
$810.50
+2.30%
UNH
UnitedHealth
$485.20
-2.51%
NVO
Novo Nordisk
—
—
JNJ
Johnson & Johnson
—
—
TMO
Thermo Fisher
—
—
WELL
Welltower
—
—
Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

📅 Earnings in 36d (May 20)
Medtronic PLC

Medtronic PLC

Health Care·NEW YORK STOCK EXCHANGE, INC.·IE·IPO 1977-11-21
  • Yahoo·4h ago

    Jim Cramer Says “Don’t Mess With Alphabet, They’re Crushing It”

    Alphabet Inc. (NASDAQ:GOOGL) is among Jim Cramer’s recent stock calls as he urged investors to stand by the defense sector. A club member asked whether their portfolio is diverse enough if their top 5 holdings are GOOGL, AAPL, MDT, MPLX, and RTX. In response, Cramer said: Okay, I’m liking what I see here. One of […]

  • Yahoo·11h ago

    EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors

    Research identifies guideline-based interpretation gaps and signal-detection issues behind non-actionable alerts and shows how an additional cloud-based AI layer can significantly reduce clinician review burden while maintaining high sensitivityCAMBRIDGE, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining why

  • Benzinga·1d ago

    Mizuho Maintains Outperform on Medtronic, Lowers Price Target to $120

    Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $125 to $120.

  • Yahoo·1d ago

    Medtronic to announce financial results for its fourth quarter and full fiscal year 2026

    Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, for its fourth quarter and full fiscal year 2026, which ends on Friday, April 24, 2026.

  • Yahoo·2d ago

    Medtronic plc (MDT): Innovation Pipeline and Structural Changes Support the Bull Case

    Medtronic plc (NYSE:MDT) is one of the undervalued large cap stocks to buy. On April 6, Argus Research analyst David Toung cut his price target on Medtronic plc (NYSE:MDT) to $115 from $125 and maintained a Buy rating. Toung’s bullishness on the stock despite the target cut stems from Medtronic’s structural transformation. This is in […]

  • Yahoo·3d ago

    GE HealthCare Ultrasound Link With Medtronic Adds New Neurosurgery Angle

    GE HealthCare Technologies (NasdaqGS:GEHC) has launched a digital integration between its bkActiv ultrasound system and Medtronic's Stealth AXiS surgical navigation platform. The combined solution is now commercially available for neurosurgical procedures, offering real time imaging support in cranial surgery. The integration is designed to address brain shift during operations, a key challenge that can affect surgical accuracy. For investors watching GE HealthCare at a share price of...

  • SeekingAlpha·4d ago

    Dividend Champion, Contender, And Challenger Highlights: Week Of April 12

    A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list here.

  • Yahoo·4d ago

    Medtronic Neurosurgery Imaging Tie Up May Influence Digital Surgery Valuation

    GE HealthCare and Medtronic (NYSE:MDT) have launched a digital integration between the bkActiv intraoperative ultrasound and the Stealth AXiS surgical navigation system. The integration is now commercially available and is designed to support cranial neurosurgery with real-time imaging during procedures. This launch connects Medtronic's navigation and robotics platforms with GE HealthCare's imaging into a unified workflow in the operating room. For you as an investor, this update sits at...

  • View all news →
NEW YORK STOCK EXCHANGE, INC.After-hours
Medtronic PLC
Health Care
—
— (—)
Open
—
Prev close
—
Day range
— – —
52W range
$79.93 – $106.33
Mkt cap
$112.98B
P/E
24.6
EPS
$3.58
Beta
0.73

Fundamentals

Valuation
Market Cap
$112.98B
P/E (TTM)
24.62S&P avg ~22
P/S (TTM)
3.20S&P avg ~2.8
P/B
2.64S&P avg ~4.5
P/FCF
21.01S&P avg ~26
EPS (TTM)
$3.58
Book/sh
$38.17
Cash/sh
$6.53
Profitability
Gross Margin
65.16%avg ~45%
Operating Margin
17.00%avg ~15%
Net Margin
13.01%avg ~12%
ROE
9.54%avg ~18%
ROA
5.05%avg ~7%
ROI
6.00%
Payout Ratio
78.60%
FCF/sh
—
Growth & Health
Rev Growth YoY
6.88%
Rev Growth 5Y
3.01%
EPS Growth YoY
8.94%
EPS Growth 5Y
0.39%
Current Ratio
—
Quick Ratio
1.87
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
0.73
52W High
$106.33
52W Low
$79.93
Avg Vol (10D)
7.69M
Avg Vol (3M)
7.79M
Div Yield
3.23%
Div/sh (TTM)
—
Analyst
Buy (37)
Price Performance
5D+1.83%
MTD+1.56%
3M-10.83%
6M-10.60%
YTD-8.39%
1Y+6.62%

Factor Grades

View details →
C+
Overall score: 58/100
B-
Valuation
C
Growth
B-
Profitability
D
Momentum
A-
Financial Health
⚠️
Dilution risk detected

4 offering-related filings in the last 60 filings. Latest: S-3ASR on 2026-03-09. View all →

Recent insider activity

View all →
  • 4FORM 4
    Mar 5
  • 4FORM 4
    Feb 26
  • 4FORM 4
    Feb 24
  • 4FORM 4
    Feb 2
  • 4FORM 4
    Dec 17